• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.61 -$0.01 (-0.07%)

REAL-TIME: Last trade at

Human Genome Sciences

NASDAQ:HGSI

Jump to this page for:

Related Resources

Human Genome Shareholders Should Not Get Greedy

5/25/2012 by Seeking Alpha

Top Analyst Upgrades & Downgrades (ADI, ARMH, AGO, BHI, DF, DELL, DUK, EV, EXPR, HPQ, HGSI, IRDM, ME

5/24/2012 by 247wallst

Glaxo Amends Offer To Address HGS Shareholder Rights Plan

5/23/2012 by Smart Money

Greece Steals the Dow's Lunch Money

5/23/2012 by DailyFinance

How to Play an Arena Delay

5/22/2012 by DailyFinance

What These Winning Investments Can Teach You

5/21/2012 by DailyFinance

Glaxo Fails to Impress HGSI - Analyst Blog

5/18/2012 by Nasdaq

Glaxo Hikes Stake in Theravance - Analyst Blog

5/17/2012 by Nasdaq

Human Genome Looks to Anyone but GlaxoSmithKline

5/17/2012 by Nasdaq

ADR Report: Shares Lower As Euro-Zone Worries Loom

5/17/2012 by Smart Money

UPDATE: Human Genome Adopts Poison Pill With 15% Trigger To Deter Glaxo

5/17/2012 by Smart Money

Glaxo Set to Acquire Cellzome - Analyst Blog

5/16/2012 by Nasdaq

Glaxo's Acne Drug Gets U.S. Nod - Analyst Blog

5/14/2012 by Nasdaq

Hostile Takeover? More Like Nice Guy Showdown.

5/11/2012 by DailyFinance

Glaxo Goes Hostile With $2.6 Billion Bid

5/10/2012 by DailyFinance

Top Analyst Upgrades & Downgrades (ARMH, BIG, CHKM, CSCO, CPWM, DLB, HGSI, JDSU, LINE, MMM, NOV, ORC

5/10/2012 by 247wallst

GlaxoSmithKline PLC GSK commences tender offer to acquire HGS

5/10/2012 by Smart Money

Best of the Blogs, Biotech: Will New HIV Prevention Pill Create More Dangerous Strains?

5/10/2012 by Minyanville

Glaxo Continues to Chase HGSI - Analyst Blog

5/10/2012 by Nasdaq

Key Short Interest Changes in Cult Stocks & Controversial Stocks (ALU, STD, BAC, BKS, DNDN, DMND, FS

5/10/2012 by 247wallst

Dow Poised for Further Losses?

5/9/2012 by DailyFinance

GlaxoSmithKline to Get Hostile with Offer for Human Genome

5/9/2012 by Nasdaq

Glaxo Goes Direct To HGS Shareholders With Hostile Offer

5/9/2012 by Smart Money

Media Digest (5/9/2012) Reuters, WSJ, NYT, FT, Bloomberg

5/9/2012 by 247wallst

GlaxoSmithKline Goes Hostile in Bid for Human Genome Sciences

5/9/2012 by Minyanville

Why Dynavax Shares Dropped

5/9/2012 by DailyFinance

Ahead of Wall Street - May 9, 2012 - Ahead of Wall Street

5/9/2012 by Nasdaq

WSJ BLOG/Health: A.M. Vitals: GSK's Hostile Human Genome Bid; Regulators Like Preventive HIV Drug

5/9/2012 by Smart Money

Is Human Genome Sciences the Perfect Stock?

5/2/2012 by DailyFinance

This Biotech Rejects a Gift Offer

5/1/2012 by DailyFinance

1 Big Pharma Restocking Its Pipeline

5/1/2012 by DailyFinance

Sequenom Starts to Show It

4/30/2012 by DailyFinance

Human Genome Holder Says Glaxo Bid "Unacceptable" - Newspaper

4/29/2012 by Smart Money

Stocks Shaking the Investment World

4/27/2012 by DailyFinance

Come On, Amylin, Just a Little Clue?

4/27/2012 by DailyFinance

Glaxo Misses Estimates Again - Analyst Blog

4/26/2012 by Nasdaq

HGSI Cuts Loss on Benlysta Sales - Analyst Blog

4/26/2012 by Nasdaq

Glaxo Lifts 2012 Share Buyback Target As Sales Growth Returns

4/25/2012 by Smart Money

UPDATE: Glaxo Lifts Share Buyback Target As Sales Growth Returns

4/25/2012 by Smart Money

Human Genome Lays Out Its Valuation Case

4/25/2012 by DailyFinance
See More Articles...